FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Virtual Regulated Bioanalysis Workshop

FDA announces a 6/30 virtual meeting entitled Regulated Bioanalysis Workshop: Requirements and Expectations.

Human Drugs

Adamas sNDA for Parkinsons Drug

FDA accepts for review an Adamas Pharmaceuticals supplemental NDA for Gocovri (amantadine) as a treatment for off episodes in Parkinson's disease pati...

Medical Devices

Transit Scientific XO PTA Scoring Sheath Cleared

FDA clears a Transit Scientific 510(k) for its XO Score Percutaneous Transluminal Angioplasty Scoring Sheath platform for use in iliac, ilio-femoral, ...

Federal Register

Fed Reg on ICH Solvents Corrected

Federal Register notice: FDA corrects a 5/27 notice on a guidance entitled Q3C (R8) Recommendations for the Permitted Daily Exposures for Three Solven...

Federal Register

EUAs Issued and Reissued During Covid Emergency

Federal Register notice: FDA announces the issuance and reissuance of Emergency Use Authorizations (EUAs) for certain medical devices related to the C...

Medical Devices

Testing Supply Substitution Strategies

FDA releases a PowerPoint slide show describing a new Web resource for labs performing Covid-19 tests that are authorized.

Human Drugs

Fitbit Emergency Use Ventilator

FDA grants Fitbit an emergency use authorization for its emergency ventilator, Fitbit Flow, for use during the Covid-19 public health emergency.

Human Drugs

FDA Reminder on Proper Transport Media

FDA reminds laboratories to use transport media that are compatible with Covid-19 testing platforms and the processes used in their laboratory to proc...

Human Drugs

FDA Regulatory Flexibility for Antimicrobials Analyzed

Harvard Medical School researchers say that in the last 30 years antimicrobial products have frequently qualified for FDA expedited clinical testing a...

Biologics

Favored Vaccine Candidates Got Public Funding: Report

Public Citizen calls for publication of federal contracts with five leading candidates to manufacture a Covid-19 vaccine, all of whom have received si...